MedTech News
Nevro wins CE mark for HFX iQ spinal cord stim for pain relief
Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.
Magstim earns FDA clearance for transcranial magnetic stimulation that treats depression, OCD
Magstim announced today that the FDA cleared its next-generation Horizon Inspire system for delivering transcranial magnetic stimulation (TMS).
FDA clears AI-powered breast cancer detection tech from iCad
iCad (Nasdaq:ICAD) announced today that the FDA cleared its ProFound Detection version 4.0 for digital breast tomosynthesis (DBT).
Philips wins FDA clearance for new detector-based radiotherapy system
Philips (NYSE:PHG) announced today that the FDA granted 510(k) clearance for its new detector-based spectral computed tomography (CT) radiotherapy solution.
BioInteractions launches fibrin sheath prevention breakthrough at COMPAMED 2024
Fibrin sheath formation is a challenge for physicians using CVCs, as it blocks blood flow and makes CVCs less effective; the new AstutePlus prevents fibrin sheath formation.
Accunea showcases new kidney care device at COMPAMED 2024
MedTech startup Accunea has developed RenoSure, a new device that has been designed to ‘transform’ kidney care according to the company, and increase the number of organs available for transplantation.
Billerud launches new surface-treated medical paper at COMPAMED
MediKraft SealBase is a surface-treated medical paper that the company says is designed to meet the growing needs of the medical packaging industry.
Momentis Surgical Receives FDA 510(k) Clearance for Second Generation Anovo® Robotic Platform, Introducing Haptic Feedback and Dual-Mode Articulation
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Nov. 11, 2024 /PRNewswire/ — Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo® robotic surgical platform.